Zeng Wen-Jiao, Liu Guo-Yuan, Xu Jie, Zhou Xin-Da, Zhang Yue-E, Zhang Nong
Department of Pathology, Medical School of Fudan University, Shanghai, China.
World J Gastroenterol. 2002 Dec;8(6):1040-4. doi: 10.3748/wjg.v8.i6.1040.
To study the relationship between prognosis and pathological characteristics, proliferating cell nuclear antigen labeling index (PCNA-LI) and DNA index (DI) in patients with moderately differentiated hepatocellular carcinoma(HCC).
51 cases of moderately differentiated HCC were analyzed with respect to the relation between their clinical follow-up data and pathological characteristics. Meanwhile, PCNA-LI of HCC cells was detected by immunohistochemistry assay and DI was measured by Feulgen staining and automatic image analysis technique.
Patients with a single tumor nodule, less than 5 cm in diameter, no tumor emboli, no daughter nodules and necrosis had relatively better prognosis; patients with euploidy HCC had better prognosis than those with aneuploidy; among the aneuploidy patients those with DI<1.5 had better prognosis than the cases with DI>1.5; The higher the PCNA-LI, the worse would be the prognosis. The increase in DI was correlated with the increase in PCNA-LI, and both of them were correlated with the pathological changes of the tumor.
A composite analysis of the pathological characteristics of tumor tissue, DI and PCNA-LI might be useful in predicting the prognosis of HCC patients.
研究中度分化肝细胞癌(HCC)患者的预后与病理特征、增殖细胞核抗原标记指数(PCNA-LI)及DNA指数(DI)之间的关系。
对51例中度分化HCC患者的临床随访资料与病理特征之间的关系进行分析。同时,采用免疫组织化学法检测HCC细胞的PCNA-LI,并用Feulgen染色和自动图像分析技术测定DI。
肿瘤结节为单个、直径小于5 cm、无肿瘤栓子、无子结节及坏死的患者预后相对较好;二倍体HCC患者的预后优于非整倍体患者;在非整倍体患者中,DI<1.5者的预后优于DI>1.5者;PCNA-LI越高,预后越差。DI的升高与PCNA-LI的升高相关,且二者均与肿瘤的病理变化相关。
对肿瘤组织的病理特征、DI及PCNA-LI进行综合分析可能有助于预测HCC患者的预后。